ACRACRUX LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 14 Aug 2026, 19:50 | Webinar invitation for 17 August 2026, 11am | Presentations | — | 14014 | |
| 13 Aug 2026, 19:31 | Application for quotation of securities - ACR | Other | — | 06020 | |
| 13 Aug 2026, 19:27 | Notification of cessation of securities - ACR | Other | — | 06027 | |
| 6 Aug 2026, 19:02 | Investor Presentation - Female Testosterone for HSDD | Presentations | MS | 03026 | |
| 31 July 2026, 20:07 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 29 July 2026, 20:16 | Cleansing Notice | Securities Administration | — | 06018 | |
| 29 July 2026, 20:12 | Application for quotation of securities - ACR | Other | — | 06020 | |
| 29 July 2026, 20:09 | Notification regarding unquoted securities - ACR | Other | — | 06021 | |
| 24 July 2026, 19:20 | Appendix 3Y Dobinson | Director Interests | — | 02009 | |
| 24 July 2026, 19:18 | Application for quotation of securities - ACR | Other | — | 06020 | |
| 21 July 2026, 21:52 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 26 June 2026, 01:03 | Application for quotation of securities - ACR | Other | — | 06020 | |
| 15 June 2026, 19:30 | Notice of Extraordinary General Meeting/Proxy Form | Meetings & Governance | — | 08002, 08004 | |
| 3 June 2026, 00:17 | Appendix 3Y Oldham | Director Interests | — | 02009 | |
| 2 June 2026, 19:23 | Appendix 3Y Dobinson | Director Interests | — | 02009 | |
| 2 June 2026, 19:22 | Appendix 3Y Brumley | Director Interests | — | 02009 | |
| 2 June 2026, 19:21 | Application for quotation of securities - ACR | Other | — | 06020 | |
| 2 June 2026, 19:12 | Notification of cessation of securities - ACR | Other | — | 06027 | |
| 2 June 2026, 19:12 | Application for quotation of securities - ACR | Other | — | 06020 | |
| 29 May 2026, 22:19 | Update - Licensing Lenzetto for Australia for AUD5.4m | Company Update | MS | 11001 | |
| 28 May 2026, 19:04 | Acrux licenses Lenzetto for Australian market for AUD5.4m | Company Update | MS | 11001 | |
| 18 May 2026, 19:50 | Cleansing Notice | Securities Administration | — | 06018 | |
| 18 May 2026, 19:49 | Application for quotation of securities - ACR | Other | — | 06020 | |
| 14 May 2026, 19:26 | Capital Gains Tax exemptions remain in place for Acrux | Periodic Reports | MS | 03014, 12008 | |
| 11 May 2026, 20:58 | Proposed issue of securities - ACR | Securities Administration | — | 06013 | |
| 11 May 2026, 20:58 | Acrux raises $1.6 million via Share Placement | Capital Raising | MS | 06003, 09014 | |
| 7 May 2026, 18:58 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 1 May 2026, 02:57 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 28 Apr 2026, 19:56 | Acrux strategy focuses on Female Testosterone for low libido | Company Update | MS | 03026, 11001 | |
| 12 Mar 2026, 21:01 | Acrux receives $0.55m advance on FY26 R&D Tax Incentive | Periodic Reports | MS | 03014, 12008 | |
| 26 Feb 2026, 20:59 | Notification of cessation of securities - ACR | Other | — | 06027 | |
| 25 Feb 2026, 20:36 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 29 Jan 2026, 19:55 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 12 Dec 2025, 20:26 | Divestment of Prilocaine 2.5% and Lidocaine 2.5%, Cream | Mergers & Acquisitions | MS | 07002, 11001 | |
| 3 Dec 2025, 22:11 | Appendix 3Y Warmbrunn | Director Interests | — | 02009 | |
| 3 Dec 2025, 22:11 | Notification regarding unquoted securities - ACR | Other | — | 06021 | |
| 3 Dec 2025, 21:09 | Notification of cessation of securities - ACR | Other | — | 06027 | |
| 3 Dec 2025, 20:47 | Appendix 3Y Brooke | Director Interests | — | 02009 | |
| 3 Dec 2025, 20:46 | Appendix 3Y Oldham | Director Interests | — | 02009 | |
| 3 Dec 2025, 20:45 | Appendix 3Y Brumley | Director Interests | — | 02009 | |
| 3 Dec 2025, 20:42 | Appendix 3Y Dobinson | Director Interests | — | 02009 | |
| 3 Dec 2025, 20:41 | Notification regarding unquoted securities - ACR | Other | — | 06021 | |
| 25 Nov 2025, 22:37 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 25 Nov 2025, 19:37 | AGM Presentation and Address | Presentations | MS | 03026, 15002 | |
| 24 Nov 2025, 19:38 | Notification of cessation of securities - ACR | Other | — | 06027 | |
| 24 Nov 2025, 19:37 | Appendix 3Y Oldham | Director Interests | — | 02009 | |
| 24 Nov 2025, 19:36 | Appendix 3Y Brumley | Director Interests | — | 02009 | |
| 24 Nov 2025, 19:36 | Application for quotation of securities - ACR | Other | — | 06020 | |
| 13 Nov 2025, 19:21 | Acrux receives $0.4m advance on FY26 R&D Tax Incentive | Periodic Reports | MS | 03014, 12008 | |
| 4 Nov 2025, 20:20 | Updated September Quarter Activities Statement and App4C | Quarterly Reports | — | 19001, 19006 |
1–50 of 57
1 / 2